The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
IBA is the worldwide leader in proton therapy technology. 65% of proton therapy patients have been treated using IBA technology to date. The company has been leading proton therapy for the last 30 years and has built the largest user community of the world's best proton therapy centers.
Philips look beyond technology to the experiences of consumers, patients, providers and caregivers across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. With leading research, design and innovation capabilities, Philips partner with its customers to transform the delivery of healthcare.
Elekta innovation is responsible for introducing most of the critical technological advances in radiation oncology of the last 30 years. Elekta creates treatment solutions that provide increasing efficiency, while retaining the clinician’s right to choose the best option for individual patients. Elekta maintains its long-standing focus on evidence-based medicine.